Status:

COMPLETED

Bowel Colonization With Multi-drug Resistant Bacterial Species in Hospitalized Patients With acute-on Chronic Liver Failure (ACLF), and Its Relationship With Extra-intestinal Infectious Events and Short-term Outcomes.

Lead Sponsor:

Institute of Liver and Biliary Sciences, India

Conditions:

Acute-On-Chronic Liver Failure

Eligibility:

All Genders

18-60 years

Brief Summary

Bowel colonization with anti-microbial resistant bacteria increases the risk of clinical infections. Infections caused by anti-microbial resistant bacteria have been associated with increased mortalit...

Eligibility Criteria

Inclusion

  • \- Patients with Acute on Chronic Liver Failure admitted to the ward/High Dependency Unit/Intensive Care Unit.

Exclusion

  • Patients on immunosuppressant medications or on daily steroids (excluding inhaled steroids) or \>2 weeks.
  • Patients with additional primary or acquired immunosuppressive states like hypogammaglobinemia, post-splenectomy, human immunodeficiency virus (HIV) infection etc.
  • Neutropenia defined as absolute neutrophil count or total white blood cell count (WBC) \<500/mm3
  • Patients with extra-hepatic malignancy or on cytotoxic chemotherapy.
  • Patients with ileus, bowel hypomotility, severe constipation requiring laxatives/purgatives or enemas to evacuate.
  • Patients with fresh or altered blood in stools.
  • Patients with anatomical predisposition to infection/ bacterial seeing like prosthesis or foreign body. Patients with exfoliative skin conditions, significant mucosal ulcerations, or skin ulcers. Patients who have received \> 2 weeks of antibiotics before current admission.
  • Pregnant patients.

Key Trial Info

Start Date :

June 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2021

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04383106

Start Date

June 1 2020

End Date

December 31 2021

Last Update

March 5 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute of Liver and Biliary Sciences

New Delhi, National Capital Territory of Delhi, India, 110070